200 related articles for article (PubMed ID: 4553235)
1. Clinical study of a new anti-inflammatory drug: 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370).
Dotti F; Ongari R; Carazzi R; Chierichetti S
Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:265-8. PubMed ID: 4553235
[No Abstract] [Full Text] [Related]
2. Clinical trial of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370) in painful osteoarticular conditions.
Pasotti C; Barbieri C; Buniva G; Chierichetti S
Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:262-5. PubMed ID: 4553234
[No Abstract] [Full Text] [Related]
3. Metabolic and clinical effects of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370).
Ghiringhelli F; Mazzi C; Chierichetti S
Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:268-7. PubMed ID: 5067203
[No Abstract] [Full Text] [Related]
4. Clinical and laboratory evaluation of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370) in rheumatoid arthritis and ankylosing spondylitis.
Lignière GC; Colombo B; Carrabba M; Ferrari P; Robotti E
Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:253-8. PubMed ID: 4553232
[No Abstract] [Full Text] [Related]
5. Controlled clinical trial of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370) and oxyphenbutazone in thrombophlebitis.
Seghezzi R; Borri P; Chierichetti S; Ferrari P
Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:272-4. PubMed ID: 4553236
[No Abstract] [Full Text] [Related]
6. Clinical pharmacology of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370).
Buniva G; Cattò G; Chierichetti S; Granata D; Manieri G
Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:258-6. PubMed ID: 4553233
[No Abstract] [Full Text] [Related]
7. [Clinico-therapeutic experiences with a new anti-inflammatory agent: DA 2370].
Scanni A; Ferrari P
Minerva Med; 1973 Oct; 64(71):3718-24. PubMed ID: 4588363
[No Abstract] [Full Text] [Related]
8. Pharmacological investigations of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370). 6. Activity on polyarthritis induced in rats by Freund's adjuvant.
Lumachi B
Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:204+. PubMed ID: 5067194
[No Abstract] [Full Text] [Related]
9. Pharmacological investigations of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370). 5. Activity on acute experimental synovitis in dogs.
Lumachi B
Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:202-4. PubMed ID: 5067193
[No Abstract] [Full Text] [Related]
10. Clinical and pharmacokinetic studies of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370) in obstetrics and gynaecology.
Pecorari D; Ragni N; Chierichetti S
Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:278-8. PubMed ID: 5067205
[No Abstract] [Full Text] [Related]
11. Pharmacological investigations of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370). 7. Pharmacological comparison with standard anti-inflammatory drugs.
Marazzi-Uberti E; Lumachi B; Gaetani M; Coppi G; Bianchi C
Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:213-6. PubMed ID: 5067195
[No Abstract] [Full Text] [Related]
12. Terpene compounds as drugs. X. 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370): a new anti-inflammatory drug, with low ulcerogenic effects, derived from a series of terpenyl pyrazolidinediones.
Casadio S; Pala G; Marazzi-Uberti E; Lumachi B; Crescenzi E; Donetti A; Mantegani A; Bianchi C
Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:171-4. PubMed ID: 5067187
[No Abstract] [Full Text] [Related]
13. Structure-activity relationships in anti-inflammatory compounds chemically related to 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370).
Pala G; Mantegani A; Donetti A; Lumachi B; Marazzi-Uberti E; Casadio S
Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:174-7. PubMed ID: 5067188
[No Abstract] [Full Text] [Related]
14. Clinical and laboratory studies of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370) in bronchopulmonary diseases.
Fumagalli G; Mazzola C; Chierichetti S
Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:274-8. PubMed ID: 5067204
[No Abstract] [Full Text] [Related]
15. Toxicological investigations of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370). 3. A comparative study of short-term toxicity of DA 2370 and other non-steroid anti-inflammatory drugs (phenylbutazone, mefenamic acid, indometacin and benzydamine) in the rat.
Gaetani M; Debeus R; Vidi A; Coppi G
Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:226-3. PubMed ID: 5067198
[No Abstract] [Full Text] [Related]
16. [Clinical evaluation of mepirizole (DA-398) in the treatment of chronic rheumatoid arthritis].
Shiokawa Y; Kageyama T; Sakuma A
Ryumachi; 1973 Apr; 13(2):206-20. PubMed ID: 4581124
[No Abstract] [Full Text] [Related]
17. Survey of the biological properties of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370), a novel agent in the class of anti-inflammatory drugs.
Bianchi C
Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:249-5. PubMed ID: 5067202
[No Abstract] [Full Text] [Related]
18. [Pharmacodynamics and adverse effects of modern nonsteroid anti-inflammatory agents].
Guobis G; Iushenaite Ia
Ter Arkh; 1981; 53(7):142-51. PubMed ID: 6457407
[No Abstract] [Full Text] [Related]
19. A controlled trial of mazindol (Sanjorex, Teronac) in the management of the obese rheumatic patients.
Thorpe PC; Isaac PF; Rodgers J
Curr Ther Res Clin Exp; 1975 Feb; 17(2):149-55. PubMed ID: 803428
[No Abstract] [Full Text] [Related]
20. Evaluation of namoxyrate in the treatment of geriatric arthritics.
Cohen A; DeFelice EA; Beber CR; Shaffer JW; Forbes JA
Curr Ther Res Clin Exp; 1965 Dec; 7(12):759-68. PubMed ID: 4954446
[No Abstract] [Full Text] [Related]
[Next] [New Search]
